Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,856,105
+$43,829 QoQ
Shares Held
1,335,328
+18.6% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FMR LLC holds $5,285,587,157 across 50 Drug Manufacturers - Specialty & Generic names. AKBA ranks #26 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
50,925,366 | $1,218,644,005 | |
| 2 | HLN |
Haleon plc
|
113,969,159 | $1,140,831,280 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
33,132,795 | $997,959,784 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
4,626,453 | $350,916,458 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
6,823,700 | $328,561,152 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
528,346 | $313,298,609 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
16,630,541 | $231,164,518 | |
| 8 | VTRS |
Viatris Inc
|
16,588,514 | $224,110,822 |
All Filings in AKBA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,856,105 | 1,335,328 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,812,276 | 1,125,638 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,489,270 | 911,821 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,962,893 | 813,982 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,675,168 | 872,484 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,419,310 | 747,006 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $900,289 | 682,038 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $552,338 | 541,509 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $920,935 | 503,244 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $718,567 | 579,490 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $727,422 | 638,090 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $561,434 | 613,590 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $343,610 | 613,590 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $354,041 | 613,590 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $195,009 | 617,118 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $219,299 | 621,244 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $160,832 | 224,001 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $106 | 37 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $947 | 280 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $3,012 | 1,200 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $24,057,879 | 1,771,567 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $7,777,587 | 1,026,067 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||